Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) - Total Assets

Latest as of September 2025: CN¥2.13 Billion CNY ≈ $311.96 Million USD

Based on the latest financial reports, Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) holds total assets worth CN¥2.13 Billion CNY (≈ $311.96 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Zhejiang Shapuaisi Pharmaceutical Co Ltd - Total Assets Trend (2008–2024)

This chart illustrates how Zhejiang Shapuaisi Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Zhejiang Shapuaisi Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Zhejiang Shapuaisi Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Zhejiang Shapuaisi Pharmaceutical Co Ltd's total assets of CN¥2.13 Billion consist of 17.4% current assets and 82.6% non-current assets. Review 603168 current and long-term liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	3.9%
Accounts Receivable	CN¥80.62 Million	3.8%
Inventory	CN¥76.66 Million	3.6%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥215.83 Million	10.3%
Goodwill	CN¥332.09 Million	15.8%

Asset Composition Trend (2008–2024)

This chart illustrates how Zhejiang Shapuaisi Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Zhejiang Shapuaisi Pharmaceutical Co Ltd stock price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Zhejiang Shapuaisi Pharmaceutical Co Ltd's current assets represent 17.4% of total assets in 2024, a decrease from 50.4% in 2008.
Cash Position: Cash and equivalents constituted 3.9% of total assets in 2024, down from 4.4% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 25.0% of total assets, an increase from 4.0% in 2008.
Asset Diversification: The largest asset category is goodwill at 15.8% of total assets.

Zhejiang Shapuaisi Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Zhejiang Shapuaisi Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	India	Rs443.12 Billion
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Beijing Tongrentang Co Ltd SHG:600085	China	CN¥29.95 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	China	CN¥12.75 Billion
Harbin Pharmaceutical Group Co Ltd SHG:600664	China	CN¥14.08 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion

Zhejiang Shapuaisi Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.16	1.31	1.79
Quick Ratio	0.83	1.04	1.63
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥56.85 Million	CN¥95.49 Million	CN¥285.73 Million

Zhejiang Shapuaisi Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Zhejiang Shapuaisi Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.71
Latest Market Cap to Assets Ratio	0.15
Asset Growth Rate (YoY)	-3.0%
Total Assets	CN¥2.11 Billion
Market Capitalization	$325.19 Million USD

Valuation Analysis

Below Book Valuation: The market values Zhejiang Shapuaisi Pharmaceutical Co Ltd's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Zhejiang Shapuaisi Pharmaceutical Co Ltd's assets decreased by 3.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)

The table below shows the annual total assets of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥2.11 Billion ≈ $308.21 Million	-2.95%
2023-12-31	CN¥2.17 Billion ≈ $317.58 Million	+10.86%
2022-12-31	CN¥1.96 Billion ≈ $286.47 Million	+23.49%
2021-12-31	CN¥1.59 Billion ≈ $231.99 Million	-5.23%
2020-12-31	CN¥1.67 Billion ≈ $244.80 Million	+5.26%
2019-12-31	CN¥1.59 Billion ≈ $232.57 Million	-3.60%
2018-12-31	CN¥1.65 Billion ≈ $241.24 Million	-11.81%
2017-12-31	CN¥1.87 Billion ≈ $273.55 Million	+1.48%
2016-12-31	CN¥1.84 Billion ≈ $269.56 Million	+44.48%
2015-12-31	CN¥1.27 Billion ≈ $186.57 Million	+46.16%
2014-12-31	CN¥872.34 Million ≈ $127.65 Million	+45.98%
2013-12-31	CN¥597.57 Million ≈ $87.44 Million	+15.69%
2012-12-31	CN¥516.54 Million ≈ $75.59 Million	+57.78%
2011-12-31	CN¥327.38 Million ≈ $47.91 Million	+47.15%
2010-12-31	CN¥222.49 Million ≈ $32.56 Million	+19.09%
2009-12-31	CN¥186.82 Million ≈ $27.34 Million	+14.74%
2008-12-31	CN¥162.82 Million ≈ $23.83 Million	--

About Zhejiang Shapuaisi Pharmaceutical Co Ltd

SHG:603168 China Drug Manufacturers - Specialty & Generic

Market Cap

$325.19 Million

CN¥2.22 Billion CNY

Market Cap Rank

#14603 Global

#4395 in China

Share Price

CN¥5.94

Change (1 day)

-0.50%

52-Week Range

CN¥4.72 - CN¥8.48

All Time High

CN¥31.28